Pivotal bioVenture Partners Fund II reported a 5.5% stake in MapLight Therapeutics MPLT · 2,915,874 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 5.5%
Last report: First report
Shares held: 2,915,874 sh
Class: Common Stock, par value $0.0001 per share
Stock: MapLight Therapeutics MPLT
Holder: Pivotal bioVenture Partners Fund II
Event date: 26/08/13
Filed: 26/08/20

First 5%+ report · 5.5% stake

MapLight Therapeutics trades, last 26 weeks

What else happened in MapLight Therapeutics around then

Filed or reported within 30 days of the trade day · 07/14~09/12

Pivotal bioVenture Partners Fund II's other 5% stake reports

No other trades yet.